These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 11221853

  • 1. Chromosomal rearrangements and oncogene amplification precede aneuploidization in the genetic evolution of breast cancer.
    Rennstam K, Baldetorp B, Kytölä S, Tanner M, Isola J.
    Cancer Res; 2001 Feb 01; 61(3):1214-9. PubMed ID: 11221853
    [Abstract] [Full Text] [Related]

  • 2. Genetic aberrations in hypodiploid breast cancer: frequent loss of chromosome 4 and amplification of cyclin D1 oncogene.
    Tanner MM, Karhu RA, Nupponen NN, Borg A, Baldetorp B, Pejovic T, Fernö M, Killander D, Isola JJ.
    Am J Pathol; 1998 Jul 01; 153(1):191-9. PubMed ID: 9665480
    [Abstract] [Full Text] [Related]

  • 3. Characterization of topoisomerase II alpha gene amplification and deletion in breast cancer.
    Järvinen TA, Tanner M, Bärlund M, Borg A, Isola J.
    Genes Chromosomes Cancer; 1999 Oct 01; 26(2):142-50. PubMed ID: 10469452
    [Abstract] [Full Text] [Related]

  • 4. New amplified and highly expressed genes discovered in the ERBB2 amplicon in breast cancer by cDNA microarrays.
    Kauraniemi P, Bärlund M, Monni O, Kallioniemi A.
    Cancer Res; 2001 Nov 15; 61(22):8235-40. PubMed ID: 11719455
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Polysomy of chromosome 17 in breast cancer tumors showing an overexpression of ERBB2: a study of 175 cases using fluorescence in situ hybridization and immunohistochemistry.
    Salido M, Tusquets I, Corominas JM, Suarez M, Espinet B, Corzo C, Bellet M, Fabregat X, Serrano S, Solé F.
    Breast Cancer Res; 2005 Nov 15; 7(2):R267-73. PubMed ID: 15743507
    [Abstract] [Full Text] [Related]

  • 10. Novel gene rearrangements in transformed breast cells identified by high-resolution breakpoint analysis of chromosomal aberrations.
    Unger K, Wienberg J, Riches A, Hieber L, Walch A, Brown A, O'Brien PC, Briscoe C, Gray L, Rodriguez E, Jackl G, Knijnenburg J, Tallini G, Ferguson-Smith M, Zitzelsberger H.
    Endocr Relat Cancer; 2010 Mar 15; 17(1):87-98. PubMed ID: 19858224
    [Abstract] [Full Text] [Related]

  • 11. Chromosomal 20q gain in the DNA diploid component of aneuploid colorectal carcinomas.
    De Angelis PM, Stokke T, Beigi M, Flatberg G, Enger M, Haug K, Aass HC, Schjølberg A, Andresen PA, Ariansen S, Bø AS, Mjåland O, Clausen OP.
    Int J Cancer; 2007 Jun 15; 120(12):2734-8. PubMed ID: 17354231
    [Abstract] [Full Text] [Related]

  • 12. Analysis of ERBB2 and TOP2A gene status using fluorescence in situ hybridization versus immunohistochemistry in localized breast cancer.
    Bouchalová K, Trojanec R, Kolár Z, Cwiertka K, Cernáková I, Mihál V, Hajdúch M.
    Neoplasma; 2006 Jun 15; 53(5):393-401. PubMed ID: 17013533
    [Abstract] [Full Text] [Related]

  • 13. Gene copy mapping of the ERBB2/TOP2A region in breast cancer.
    Jacobson KK, Morrison LE, Henderson BT, Blondin BA, Wilber KA, Legator MS, O'Hare A, Van Stedum SC, Proffitt JH, Seelig SA, Coon JS.
    Genes Chromosomes Cancer; 2004 May 15; 40(1):19-31. PubMed ID: 15034864
    [Abstract] [Full Text] [Related]

  • 14. Mammary tumors in mice conditionally mutant for Brca1 exhibit gross genomic instability and centrosome amplification yet display a recurring distribution of genomic imbalances that is similar to human breast cancer.
    Weaver Z, Montagna C, Xu X, Howard T, Gadina M, Brodie SG, Deng CX, Ried T.
    Oncogene; 2002 Aug 01; 21(33):5097-107. PubMed ID: 12140760
    [Abstract] [Full Text] [Related]

  • 15. [Relationship between aneuploidy of chromosome 17 and amplification of HER-2/neu gene in the different histological type of breast cancer].
    Kuroso K, Ueda Y, Mori Y.
    Rinsho Byori; 2004 Nov 01; 52(11):897-9. PubMed ID: 15658468
    [Abstract] [Full Text] [Related]

  • 16. DNA content and chromosomal composition of malignant human gliomas.
    Bigner SH, Bjerkvig R, Laerum OD.
    Neurol Clin; 1985 Nov 01; 3(4):769-84. PubMed ID: 3001489
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Molecular cytogenetic characterization of human breast cancer cell line MDA-MB-468 and its variant 468LN, which displays aggressive lymphatic metastasis.
    Xu J, Chambers AF, Tuck AB, Rodenhiser DI.
    Cancer Genet Cytogenet; 2008 Feb 01; 181(1):1-7. PubMed ID: 18262045
    [Abstract] [Full Text] [Related]

  • 19. Analysis of aneusomy level and HER-2 gene copy number and their effect on amplification rate in breast cancer specimens read as 2+ in immunohistochemical analysis.
    Merola R, Mottolese M, Orlandi G, Vico E, Cognetti F, Sperduti I, Fabi A, Vitelli G, Cianciulli AM.
    Eur J Cancer; 2006 Jul 01; 42(10):1501-6. PubMed ID: 16762541
    [Abstract] [Full Text] [Related]

  • 20. Genome-wide allelic state analysis on flow-sorted tumor fractions provides an accurate measure of chromosomal aberrations.
    Corver WE, Middeldorp A, ter Haar NT, Jordanova ES, van Puijenbroek M, van Eijk R, Cornelisse CJ, Fleuren GJ, Morreau H, Oosting J, van Wezel T.
    Cancer Res; 2008 Dec 15; 68(24):10333-40. PubMed ID: 19074902
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.